Appili Therapeutics Stock Analysis

Appili Stock Analysis Notes

The company has price-to-book (P/B) ratio of 1.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. Appili Therapeutics recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada. APPILI THERAPEUTICS is traded on Toronto Stock Exchange in Canada. For more info on Appili Therapeutics please contact Cilla MBA at 902 442 4655 or go to https://appilitherapeutics.com.

Appili Therapeutics Investment Alerts

Appili Largest EPS Surprises

View All Earnings Estimates

Appili Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Appili Therapeutics's market, we take the total number of its shares issued and multiply it by Appili Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Appili Profitablity

Management Efficiency

Appili Therapeutics has return on total asset (ROA) of (2.6927) % which means that it has lost $2.6927 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (9.3872) %, meaning that it generated substantial loss on money invested by shareholders. Appili Therapeutics' management efficiency ratios could be used to measure how well Appili Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 17th of February 2026, Return On Capital Employed is likely to grow to 0.02, while Return On Tangible Assets are likely to drop (1.05). At this time, Appili Therapeutics' Other Current Assets are very stable compared to the past year. As of the 17th of February 2026, Debt To Assets is likely to grow to 3.83, while Total Assets are likely to drop about 2.6 M.

Technical Drivers

As of the 17th of February 2026, Appili Therapeutics shows the Mean Deviation of 9.32, risk adjusted performance of 0.0635, and Downside Deviation of 20.57. Appili Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Appili Therapeutics Price Movement Analysis

Appili Therapeutics Outstanding Bonds

Appili Therapeutics Predictive Daily Indicators

Appili Therapeutics Forecast Models

Appili Therapeutics' time-series forecasting models are one of many Appili Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Appili Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Appili Therapeutics Debt to Cash Allocation

Appili Therapeutics has accumulated 12.29 M in total debt. Appili Therapeutics has a current ratio of 1.95, which is within standard range for the sector. Debt can assist Appili Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Appili Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Appili Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Appili to invest in growth at high rates of return. When we think about Appili Therapeutics' use of debt, we should always consider it together with cash and equity.

Appili Therapeutics Total Assets Over Time

Appili Therapeutics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Appili Therapeutics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Appili Therapeutics Debt Ratio

383.0

It appears that most of the Appili Therapeutics' assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Appili Therapeutics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Appili Therapeutics, which in turn will lower the firm's financial flexibility.

Appili Therapeutics Corporate Bonds Issued

Appili Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Appili Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Appili shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Appili Therapeutics. By using and applying Appili Stock analysis, traders can create a robust methodology for identifying Appili entry and exit points for their positions.

Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.